C-X3-C Motif Chemokine Ligand 1 (CX3CL1) Antibody

Este producto es parte de CX3C - Chemokine C-X3-C-Motif (Ligand)
C-X3-C Motif Chemokine Ligand 1 (CX3CL1) Antibody

Pida mas información

935106861

info@markelab.com

Precio

416€ (200 µl)

Antibody anti-CX3CL1

proveedor

Abbexa

reference

abx430711

Tested Applications

P-ELISA, WB

reactivity

Human

status

RUO

clonality

Polyclonal

Descripción

CX3CL1 Antibody is a Goat Polyclonal antibody against CX3CL1.

Características del producto

category

Primary Antibodies


clonality

Polyclonal


reactivity

Human


immunogen target

C-X3-C Motif Chemokine Ligand 1 (CX3CL1)


host

Goat


isotype

IgG


conjugation

Unconjugated


form

Liquid


tested applications

P-ELISA, WB


purification

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.


recommended dilution

P-ELISA: 1/128000. Optimal dilutions/concentrations should be determined by the end user.


buffer

Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin.


size 1

200 µl


storage

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.


or code

CX3CL1


dry ice

No


availability

Shipped within 5-10 working days.


alias

NTN,NTT,CXC3,CXC3C,SCYD1,ABCD-3,C3Xkine,fractalkine,neurotactin


NCBI accession

NP_002987.1


note

Concentration: 0.5 mg/ml -


Quizá le pueda interesar

Human Fractalkine(Chemokine C-X3-C-Motif Ligand 1) ELISA Kit

Human Fractalkine(Chemokine C-X3-C-Motif Ligand 1) ELISA Kit

proveedor

FineTest

reference

EH0141

reactivity

human

status

RUO

Precio a consultar

Ver más

Mouse FK/CX3CL1(Fractalkine) ELISA Kit

Mouse FK/CX3CL1(Fractalkine) ELISA Kit

proveedor

FineTest

reference

EM0008

reactivity

mouse

status

RUO

Precio a consultar

Ver más

Rat Fractalkine/CX3CL1(Chemokine C-X3-C-Motif Ligand 1) ELISA Kit

Rat Fractalkine/CX3CL1(Chemokine C-X3-C-Motif Ligand 1) ELISA Kit

proveedor

FineTest

reference

ER0024

reactivity

rat

status

RUO

Precio a consultar

Ver más